🔗 Share this article

Chancellor Reeves has stated she is planning "specific steps to address cost of living issues" in the forthcoming financial statement.

During an interview with the BBC, she stated that curbing price rises is a collective task of both the government and the Bank of England.

The United Kingdom's inflation rate is forecast to be the highest among the Group of Seven advanced economies this year and the following year.

Possible Energy Bill Interventions

Sources suggest the administration could intervene to reduce energy bills, for example by slashing the current 5% level of value-added tax charged on energy.

A further option is to lower some of the government charges presently included in household expenses.

Fiscal Constraints and Expert Expectations

The government will receive the next draft from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will clarify how much space there is for such measures.

The view from most economists is that Reeves will have to announce higher taxes or expenditure reductions in order to fulfill her self-imposed debt limits.

Earlier on the same day, analysis suggested there was a £22bn gap for the chancellor to fill, which is at the lower end of expectations.

"There's a shared task between the Bank of England and the administration to continue tackling some of the sources of price increases," the Chancellor informed reporters in the US capital, at the conferences of the International Monetary Fund and global financial institution.

Revenue Pledges and International Issues

While a great deal of the attention has been on probable tax increases, the chancellor said the latest figures from the OBR had not changed her vow to campaign commitments not to raise tax levels on income tax, VAT or social security contributions.

She blamed an "uncertain world" with growing geopolitical and commercial concerns for the fiscal tax moves, probably to be targeted on those "most able to pay."

Global Economic Disputes

Referring to apprehensions about the United Kingdom's trade ties with the Asian nation she said: "The UK's national security always come first."

Last week's declaration by China to tighten export controls on rare earths and other resources that are crucial for high-technology production led American leader the US President to threaten an extra 100% tariff on imports from China, increasing the prospect of an all-out commercial conflict between the two economic giants.

The US Treasury Secretary described the Chinese move "commercial pressure" and "a international production control attempt."

Questioned on considering the American proposal to participate in its dispute with the Asian nation, the Chancellor said she was "extremely troubled" by China's measures and encouraged the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "damaging for the world economy and creates additional headwinds."

"I believe there are fields where we should address China, but there are also valuable prospects to sell into China's economy, including banking sector and other sectors of the economic system. We've got to get that balance correct."

The Treasury chief also confirmed she was cooperating with G7 counterparts "regarding our own critical minerals plan, so that we are less reliant."

NHS Drug Costs and Investment

The Chancellor also acknowledged that the cost the National Health Service spends on drugs could go up as a consequence of ongoing discussions with the Trump administration and its drugs companies, in exchange for lower tariffs and capital.

A number of the world's largest drug companies have said lately that they are either delaying or canceling investments in the UK, with several blaming the insufficient payments they are receiving.

Last month, the government science advisor said the price the NHS spends on medicines would need to increase to prevent businesses and drug research funding departing from the UK.

The Chancellor informed media: "We have seen as a result of the cost structure, that medical research, innovative medicines have not been offered in the UK in the manner that they are in other continental states."

"The objective is to ensure that people getting care from the National Health Service are can obtain the best life-saving drugs in the world. And so we are reviewing these issues, and... seeking to secure increased capital into Britain."